---
title: "Hengrui Medicine surges 10% as Q3 profit jumps 89%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303309840.md"
description: "Hengrui Medicine (1276.HK) surges 10% in Hong Kong trading after Q3 net profit jumped 89%, beating estimates."
datetime: "2026-10-28T01:35:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303309840.md)
  - [en](https://longbridge.com/en/news/303309840.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303309840.md)
generator: "portal-rs"
---

# Hengrui Medicine surges 10% as Q3 profit jumps 89%

Hengrui Medicine (1276.HK) surged **9.57%** in Hong Kong trading to HK$**49.000**, spiking more than 5% within five minutes at one point during the session.

Third-quarter net profit soared **89%** year on year to RMB **2.458 billion**, far exceeding market expectations. Revenue climbed **20.55%** to RMB **8.95 billion**, driven by robust innovative drug sales and a **31%** increase in licensing income that included a major deal with Novo Nordisk.

For the first nine months, net profit attributable to shareholders rose **20.38%** from a year earlier.

### Related Stocks

- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)

## Related News & Research

- [Hengrui Announces Drug Inclusions in China’s 2026 NRDL](https://longbridge.com/en/news/305570916.md)
- [Hengrui presenta investigaciones innovadoras en el Congreso ESMO 2026](https://longbridge.com/en/news/303511755.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [PRESS DIGEST-New York Times business news - November 20](https://longbridge.com/en/news/306242079.md)
- [NetEase Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into NetEase (NTES)](https://longbridge.com/en/news/306200520.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**